A new intranasal therapy (MP29‐02*) is more effective than current firstline therapy regardless of season, symptom or severity. Issue 4 (26th June 2015)

Record Type:: Journal Article
Title:: A new intranasal therapy (MP29‐02*) is more effective than current firstline therapy regardless of season, symptom or severity. Issue 4 (26th June 2015)
Main Title:: A new intranasal therapy (MP29‐02*) is more effective than current firstline therapy regardless of season, symptom or severity.
Authors:: Bachert, Claus
Fokkens, Wytske
Hellings, Peter
Scadding, Glenis
Munzel, Ullrich
Mullol, Joaquim
Abstract:
Is Part Of:: Clinical and translational allergy. Volume 5:Issue 4(2015)supplement 4
Journal:: Clinical and translational allergy
Issue:: Volume 5:Issue 4(2015)supplement 4
Issue Display:: Volume 5, Issue 4 (2015)
Year:: 2015
Volume:: 5
Issue:: 4
Issue Sort Value:: 2015-0005-0004-0000
Page Start:: n/a
Page End:: n/a
Publication Date:: 2015-06-26
Subjects:: Allergic Rhinitis -- Allergic Rhinitis -- Fluticasone Propionate -- Nasal Symptom -- Median Baseline
Allergy -- Periodicals
Immunology -- Periodicals
Allergy and Immunology -- Periodicals
Hypersensitivity -- Periodicals
Immune System Phenomena -- Periodicals
616.97005
Journal URLs:: http://www.ctajournal.com/ ↗
https://onlinelibrary.wiley.com/journal/20457022 ↗
http://link.springer.com/ ↗
DOI:: 10.1186/2045-7022-5-S4-P38 ↗
Languages:: English
ISSNs:: 2045-7022
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 18418.xml